RaySearch Laboratories AB (publ) (RAY B.ST) Stock Price
RaySearch Laboratories AB (publ) Price
Revenue has compounded at 16.9% per year over the past 19 years to 1.34 B SEK. Earnings per share have grown at 10.2% per year over the last 19 years. RaySearch Laboratories AB (publ)'s net margin stands at 16.9%, up from -7.4% several years earlier. RaySearch Laboratories AB (publ) currently offers a dividend yield of about 1.52%. The payout ratio is around 45% of earnings. The dividend has grown at 18.5% per year over the past 17 years. Analysts set a median price target of 336.60 SEK, implying 70.3% above the current price. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.
RaySearch Laboratories AB (publ) stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
RaySearch Laboratories AB (publ) business model & stock analysis
Frequently asked questions about RaySearch Laboratories AB (publ)
The business model of RaySearch Laboratories AB (publ) is focused on developing innovative software solutions for radiation therapy. RaySearch provides advanced treatment planning system (TPS) software, known as RayStation, that is used by healthcare professionals to optimize cancer treatments. The company aims to improve personalized treatment accuracy while minimizing side effects and costs. RayStation integrates with various treatment delivery systems, ensuring compatibility with a wide range of radiotherapy machines. RaySearch also offers support services and training to help healthcare institutions effectively utilize their software. This business model allows RaySearch Laboratories AB (publ) to contribute to advancements in cancer treatment through cutting-edge technology.
RaySearch Laboratories AB (publ) is primarily active in the healthcare and medical technology industries.
The main competitors of RaySearch Laboratories AB (publ) in the market are Varian Medical Systems, Elekta, and Accuray Incorporated.
RaySearch Laboratories AB (publ) is a leading medical technology company based in Sweden. Established in 2000, RaySearch specializes in developing innovative software solutions for radiation therapy, including treatment planning systems and advanced algorithms. The company's products enable healthcare professionals to deliver precise and personalized cancer treatments, ultimately improving patient outcomes. RaySearch has a strong presence in the global market and collaborates with renowned research institutions and cancer centers worldwide. With a commitment to continuous innovation and expertise in radiation therapy, RaySearch Laboratories AB (publ) is dedicated to advancing cancer care through cutting-edge technology and industry-leading solutions.
RaySearch Laboratories AB (publ) has achieved several significant milestones. Firstly, the company has developed and commercialized advanced software solutions for radiation therapy planning, including the widely acclaimed RayStation®. They have continuously improved their product portfolio to meet the evolving needs of the industry. Secondly, RaySearch Laboratories AB (publ) has expanded its global footprint by establishing a strong presence in key markets worldwide. Thirdly, the company has fostered successful collaborations with leading cancer centers and research institutions, enhancing their technological advancements and clinical expertise. Lastly, RaySearch Laboratories AB (publ) has consistently delivered strong financial results, demonstrating its solid growth trajectory in the market.
RaySearch Laboratories AB (publ) is primarily present in various countries and regions around the world. Some of the key areas where the company has a strong presence include Sweden, the United States, Germany, the United Kingdom, France, China, Canada, and Japan. RaySearch Laboratories AB (publ) has established itself as a global player in the field of medical technology, specializing in advanced software solutions for radiation therapy. With its widespread presence and reach, the company continues to deliver innovative products and services to healthcare providers and professionals worldwide.
RaySearch Laboratories AB (publ) is a leading provider of innovative software solutions for radiation therapy. The company's values are centered around excellence, innovation, and patient care. With a strong corporate philosophy, RaySearch Labs is committed to continuously improving cancer treatment by developing cutting-edge technologies. They strive to empower healthcare professionals with advanced tools that optimize treatment planning and delivery, ultimately enhancing patient outcomes. RaySearch Labs' dedication to research and development ensures that they remain at the forefront of the radiation therapy industry, delivering high-quality solutions that address the evolving challenges in cancer treatment.
Analysts currently set an average price target of 336.60 SEK for the RaySearch Laboratories AB (publ) stock (median: 336.60 SEK), implying +70.3 % versus the latest price. The consensus is based on 9 analyst ratings.
9 analysts currently rate the RaySearch Laboratories AB (publ) stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect RaySearch Laboratories AB (publ) to generate revenue of 1.40 B SEK and earnings per share of 6.91 SEK.
Converted at the current exchange rate, the RaySearch Laboratories AB (publ) share trades at 17.89 EUR (197.70 SEK).
The RaySearch Laboratories AB (publ) share (RAY B.ST) is listed on 9 stock exchanges, including: NASDAQ (RSLBF), London (0GRZ.L), Frankfurt (27R.F), Düsseldorf (27R.DU), Berlin (27R.BE), Stockholm (RAY B.ST).
RaySearch Laboratories AB (publ) is a leading provider of innovative software solutions for radiation therapy planning and execution. The company operates three business areas: RayStation, RayCare, and RayIntelligence. RayStation offers a powerful software solution for radiation therapy planning. The software combines advanced technologies and clinical experience to ensure precise and effective treatment planning. RayStation provides a wide range of tools and functions for planning radiation therapy procedures, including IMRT, VMAT, and arc therapy, as well as various special techniques such as stereotactic body radiation therapy and proton therapy. RayCare provides a complete software solution for managing radiation therapy centers, including resource management, patient management, and treatment management. RayCare improves processes in radiation therapy through fast, efficient, and secure management of all tasks and workflows. RayIntelligence includes software solutions for data analysis and processing in radiation therapy. Using advanced technologies such as artificial intelligence and machine learning, RayIntelligence offers a platform for creating and visualizing data models and analyses to optimize radiation therapy. RaySearch Laboratories AB (publ) offers a wide range of products and services to ensure successful and effective radiation therapy. From planning and management to data analysis and optimization, the company provides innovative solutions and support. RaySearch Laboratories AB (publ)'s customers include hospitals, medical practices, and research institutions that want to offer high-quality and personalized radiation therapy. RaySearch Laboratories AB (publ) is pursuing a long-term growth plan to solidify its position as a worldwide leader in software solutions for radiation therapy. The company invests in research and development to continually offer innovative technologies and solutions. Additionally, the company expands its reach through partnerships and alliances with other companies and institutions worldwide. In conclusion, RaySearch Laboratories AB (publ) is an innovative and dynamic company specializing in the development and improvement of software solutions for radiation therapy. Through its three business areas and wide range of products and services, the company provides comprehensive solutions for successful and effective radiation therapy.
The expected revenue of RaySearch Laboratories AB (publ) is 1.40 B SEK. This figure is based on current financial data and reflects the company's business performance.
The expected profit of RaySearch Laboratories AB (publ) is 237.05 M SEK. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of RaySearch Laboratories AB (publ) is currently 28.61. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the RaySearch Laboratories AB (publ) stock.
The price-to-sales ratio (P/S) of RaySearch Laboratories AB (publ) is currently 4.86. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the RaySearch Laboratories AB (publ) stock.
The Eulerpool Quality Score for RaySearch Laboratories AB (publ) is 6/10.
The ISIN of RaySearch Laboratories AB (publ) is SE0000135485. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of RaySearch Laboratories AB (publ) is 905265. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of RaySearch Laboratories AB (publ) is RAY B.ST. The ticker symbol is used to trade RaySearch Laboratories AB (publ) shares on the stock exchange.
RaySearch Laboratories AB (publ) stock
RaySearch Laboratories AB (publ) Peer Group
RaySearch Laboratories AB (publ) Ticker
RaySearch Laboratories AB (publ) FIGI
All fundamentals and in-depth analysis of RaySearch Laboratories AB (publ)
Our stock analysis for RaySearch Laboratories AB (publ) stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of RaySearch Laboratories AB (publ). If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.